Company Profile
Interventional Imaging, Inc.
Cardiovascular Disease
Imaging
Other
Atrial Fibrillation
1120 Chester Ave, Ste 418
Cleveland, OH 44114
USA
www.i3mri.com
|
Incorporated in 2003
3 Employees
|
Privately Held
|
|
This Year's Highlights
- MReye (diagnostic imaging catheter) was launched in May 2006 at the ISMRM Conference in Seattle. I3 has signifcant interest from leading MR sites for this product and is currently converting this interest into solid relationships.
- I3's cardiac ablation catheter was successfully interfaced with a GE 3.0T system at Brigham & Women's Hospital. Further testing and development is underway.
- I3 has been awarded two grants by the National Institutes of Health
|
Anticipated Highlights
- Revenue ramp-up for MReye.
- Completed pre-clinical testing on cardiac ablation catheter by year-end.
- FDA filing for MReye anticipated by year-end 2006.
|
|
Corporate Mission
I3's mission is to be the leading provider of disposable interventional catheters and related products in the emerging interventionional MRI market.
I3 is targeting the interventional cardiology market for its initial products. Current products include MR-guided cardiac ablation catheters and diagnostic imaging catheters for imaging atherosclerotic plaque.
|
